Towards Safer Opioid Prescribing: A Palliative Harm Reduction Clinic for Patients with Substance Use Disorders and Cancer Related Pain

Thank you

This live web event has ended. Thank you for attending.

Description

FREE LIVE ACTIVITY

Patients with cancer and opioid/substance use disorder (SUD) face two potentially terminal illnesses—death from cancer and death from the consequences of drug use. Their risk can be further exacerbated when they experience severe cancer-related pain, for which opioid therapy is the mainstay of cancer treatment. Traditional models of pain management and addiction medicine are not designed to serve the complex physical and psychosocial needs of patients with cancer-related pain and concurrent SUD. This leaves patients with limited options to receive high-quality symptom management in a safe manner.

In this talk, we will discuss the creation of the Palliative Ham Reduction and Resiliency Clinic at The Ohio State Wexner Medical Center. This is a Palliative Medicine clinic with additional resources and support for patients with concurrent SUDs—including additional psycho-social support, substance use evaluation and management, and coordination of care. We provide care for patients with active cancer and concurrent substance abuse or misuse. We will discuss implementing a culture of (1) patient-centeredness, (2) safety, (3) collaboration, and (4) Addiction support into our clinic model. We will also discuss our philosophy on safer opioid prescribing and harm reduction.

Learning Objectives:

Develop a team-based approach to provide care for patients with non-prescribed substance use or substance use disorders within the context of cancer pain management.
Incorporate Harm Reduction into Palliative/Supportive Care Practice.

Accreditation: The American Academy of Pain Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation: The American Academy of Pain Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

If you wish to claim CME - please visit https://www.pathlms.com/aapm/courses/55416 to complete your evaluation and PCSS survey.

Funding: Funding for this initiative was made possible (in part) by grant no. 6H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

For more information visit: https://pcssnow.org/
For questions email: pcss@aaap.org

Contributors

Dr. Sachin Kale, MD

I am a Palliative Medicine Physician and Associate Professor of Internal Medicine at The Ohio State University-James Cancer Center. I serve as Medical Director for Ambulatory Palliative Medicine for our Division and as Physician Champion for the Opioid Stewardship Program at The James Cancer Center. Clinically, I provide palliative care for patients with cancer. In 2020, I founded the Palliative Harm Reduction and Resiliency Clinic. This clinic is dedicated to caring for patients with cancer who have concurrent substance misuse or substance use disorders. Our clinic model has been presented to Palliative Medicine groups across the country as well as at at the American Academy of Hospice and Palliative Medicine and at the MD Anderson 5th Interdisciplinary Pain and Opioid Crisis Virtual Seminar
Justin Kullgren, PharmD, FAAHPM

Dr. Justin Kullgren is Specialty Practice Pharmacist in Palliative Medicine. As a Pain and Palliative Care Clinical Pharmacy Specialist at The Ohio State University Wexner Medical Center James Cancer Hospital, Justin consults with nurses, physicians, and other palliative interdisciplinary team members on pain and symptom management, prevention and treatment of adverse drug events, medication dosing, and monitoring and disease state management. Dr. Kullgren teaches in academia and has provided numerous continuing education presentations to nurses, palliative care trainees, pharmacists, nurse practitioners, physician assistants, and physicians. Justin is a Past President for the Society of Pain and Palliative Care Pharmacists and a Fellow of AAHPM

Thank you

Description

Contributors

Dr. Sachin Kale, MD

Justin Kullgren, PharmD, FAAHPM